See also this year's filing and all EDGAR filings for this company.
PDF Report 0001633932_2021_ESSA_Pharma_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001633932')"} |
Graph
Absolute values for 0001633932, ESSA Pharma Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 80,296,928 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 277,637 |
4 | LiabilitiesCurrent | 1,203,324 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 127,376 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 11,373,952 |
9 | ResearchAndDevelopmentExpense | 12,145,968 |
10 | remainder_Expenses | 329,462 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 404,012 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 80,574,565 |
1 | Liabilities | 1,330,700 |
2 | Expenses | 23,849,382 |
3 | Revenues | 0 |
4 | StockholdersEquity | 79,243,865 |
5 | NetIncome | -23,445,370 |
6 | ComprehensiveNetIncome | -23,445,370 |
7 | BaseVar | 53,079,330 |
8 | EconomicCapitalRatio | 2.76 |